Advertisement
Screener

PRECIGEN, INC. (PGEN) Income Taxes Paid

PRECIGEN, INC. Income Taxes Paid

PRECIGEN, INC. (PGEN) reported Income Taxes Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:IncomeTaxesPaid · last filed 2026-08-04

  • PRECIGEN, INC. income taxes paid for the quarter ending 2025-12-31 was $0.00.
  • PRECIGEN, INC. income taxes paid for the quarter ending 2025-09-30 was $0.00.
  • PRECIGEN, INC. income taxes paid for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • PRECIGEN, INC. income taxes paid for the quarter ending 2024-09-30 was $0.00.
  • PRECIGEN, INC. income taxes paid for fiscal 2025 was $3.00K, a 25.00% decline from fiscal 2024.
  • PRECIGEN, INC. income taxes paid for fiscal 2024 was $4.00K, a 80.95% decline from fiscal 2023.
  • PRECIGEN, INC. income taxes paid for fiscal 2023 was $21.00K.
  • PRECIGEN, INC. income taxes paid for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
Period endIncome Taxes Paid 3 monthIncome Taxes Paid 6 monthIncome Taxes Paid 9 monthIncome Taxes Paid 12 month
2026-06-30$0.00
10-Q · filed 2026-08-04
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$0.00
derived: sum of 2 quarters · filed 2026-03-25
$3.00K
10-K · filed 2026-03-25
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$3.00K
10-Q · filed 2025-11-13
2025-06-30$3.00K
10-Q · filed 2026-08-04
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$0.00
derived: sum of 2 quarters · filed 2026-03-25
$4.00K
10-K · filed 2026-03-25
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$4.00K
10-Q · filed 2025-11-13
2024-06-30$4.00K
10-Q · filed 2025-08-12
2023-12-31$21.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$21.00K
derived: sum of 2 quarters · filed 2026-03-25
$21.00K
10-K · filed 2026-03-25
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$0.00
10-Q · filed 2024-11-14
2023-06-30$0.00
10-Q · filed 2024-08-14
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
$0.00
derived: sum of 2 quarters · filed 2025-03-19
$0.00
derived: sum of 3 quarters · filed 2025-03-19
$0.00
10-K · filed 2025-03-19
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$0.00
10-Q · filed 2022-11-09
$32.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$0.00
10-Q · filed 2022-08-08
$32.00K
derived: sum of 3 quarters · filed 2024-03-19
$32.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-03-31$0.00
10-Q · filed 2022-05-09
$32.00K
derived: sum of 2 quarters · filed 2024-03-19
$32.00K
derived: sum of 3 quarters · filed 2024-03-19
$32.00K
derived: sum of 4 quarters · filed 2024-03-19
2021-12-31$32.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
$32.00K
derived: sum of 2 quarters · filed 2024-03-19
$32.00K
derived: sum of 3 quarters · filed 2024-03-19
$36.00K
10-K · filed 2024-03-19
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$4.00K
10-Q · filed 2022-11-09
$4.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$4.00K
10-Q · filed 2022-08-08
$4.00K
derived: sum of 3 quarters · filed 2023-03-06
$12.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31$4.00K
10-Q · filed 2022-05-09
$4.00K
derived: sum of 2 quarters · filed 2023-03-06
$12.00K
derived: sum of 3 quarters · filed 2023-03-06
$12.00K
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$8.00K
derived: sum of 2 quarters · filed 2023-03-06
$8.00K
derived: sum of 3 quarters · filed 2023-03-06
$48.00K
10-K · filed 2023-03-06
2020-09-30$8.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$8.00K
derived: sum of 2 quarters · filed 2021-11-08
$48.00K
10-Q · filed 2021-11-08
$48.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$40.00K
10-Q · filed 2021-08-09
$40.00K
derived: sum of 3 quarters · filed 2022-03-01
$50.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$40.00K
10-Q · filed 2021-05-10
$40.00K
derived: sum of 2 quarters · filed 2022-03-01
$50.00K
derived: sum of 3 quarters · filed 2022-03-01
$60.00K
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$10.00K
derived: sum of 2 quarters · filed 2022-03-01
$20.00K
derived: sum of 3 quarters · filed 2022-03-01
$50.00K
10-K · filed 2022-03-01
2019-09-30$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$20.00K
derived: sum of 2 quarters · filed 2020-11-09
$50.00K
10-Q · filed 2020-11-09
$73.00K
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$40.00K
10-Q · filed 2020-08-10
$63.00K
derived: sum of 3 quarters · filed 2021-03-01
$93.00K
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$30.00K
10-Q · filed 2020-05-11
$53.00K
derived: sum of 2 quarters · filed 2021-03-01
$83.00K
derived: sum of 3 quarters · filed 2021-03-01
$226.00K
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$23.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$53.00K
derived: sum of 2 quarters · filed 2021-03-01
$196.00K
derived: sum of 3 quarters · filed 2021-03-01
$216.00K
10-K · filed 2021-03-01
2018-09-30$30.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$173.00K
derived: sum of 2 quarters · filed 2019-11-12
$193.00K
10-Q · filed 2019-11-12
$262.00K
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$143.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$163.00K
10-Q · filed 2019-08-09
$232.00K
derived: sum of 3 quarters · filed 2020-03-02
$352.00K
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$20.00K
10-Q · filed 2019-05-09
$89.00K
derived: sum of 2 quarters · filed 2020-03-02
$209.00K
derived: sum of 3 quarters · filed 2020-03-02
$586.00K
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$69.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$189.00K
derived: sum of 2 quarters · filed 2020-03-02
$566.00K
derived: sum of 3 quarters · filed 2020-03-02
$566.00K
10-K · filed 2020-03-02
2017-09-30$120.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$497.00K
derived: sum of 2 quarters · filed 2018-11-08
$497.00K
10-Q · filed 2018-11-08
$507.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$377.00K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13
$377.00K
10-Q · filed 2018-08-13
$387.00K
derived: sum of 3 quarters · filed 2019-03-01
$387.00K
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$0.00
10-Q/A · filed 2018-08-13
$10.00K
derived: sum of 2 quarters · filed 2019-03-01
$10.00K
derived: sum of 3 quarters · filed 2019-03-01
2016-12-31$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$10.00K
derived: sum of 2 quarters · filed 2019-03-01
$10.00K
10-K · filed 2019-03-01
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$0.00
10-Q · filed 2017-11-09
2016-06-30$0.00
10-Q · filed 2017-08-09
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$1.17M
10-K · filed 2018-03-01
2015-09-30$1.17M
10-Q · filed 2016-11-09
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$0.00
10-K · filed 2017-03-01
2014-09-30$0.00
10-Q · filed 2015-11-09
2013-12-31$0.00
10-K · filed 2016-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Immunome Inc. (IMNM)United States$2.538B-9.45
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67